Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Fukuta
The Rituximab Maintenance Therapy Improves Prognosis of Transformed Diffuse Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Progression Free Survival at 12 Months After First-Line Therapy Is Associated With Favourable Outcomes After First Relapse/Progression in Peripheral T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Diffuse Large B-Cell Lymphoma Transformed From MALT Lymphoma Presented by Acute Abdomen
Bezmialem Science
Diffuse Large B-Cell Lymphoma
Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Multicentre Study of Primary Breast Diffuse Large B-Cell Lymphoma in the Rituximab Era
British Journal of Haematology
Hematology
Biomarkers of Diffuse Large B-Cell Lymphoma: Impact on Diagnosis, Treatment, and Prognosis
Current Biomarker Findings
Biochemistry
Clinical Biochemistry
Secondary Cutaneous Diffuse Large B-Cell Lymphoma Has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-Cell Lymphoma, Leg Type
Acta Dermato-Venereologica
Dermatology
Medicine
Is Radiotherapy Still Necessary for Diffuse Large B-Cell Lymphoma Therapy?
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era
Blood
Biochemistry
Immunology
Cell Biology
Hematology
